Scotiabank raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $450 from $433 and keeps a Sector Perform ...
KLG Q4 results show lower net sales but higher earnings. The gross margin expands 130 bps y/y on cost discipline and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback